A study to characterise the safety, tolerability and efficacy of LY4170156 in subjects with advanced solid tumors

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511238-11-00

Acronym

LOXO-FRA-24001

Enrollment

179

Registered

2024-08-09

Start date

2024-09-20

Completion date

Unknown

Last updated

2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer, endometrial cancer, non-small cell lung cancer, Ovarian cancer, pancreatic cancer and colorectal cancer., triple-negative breast cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

France, Italy, Spain

Outcome results